{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:59:34Z","timestamp":1781650774239,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","award":["Elekta"],"award-info":[{"award-number":["Elekta"]}],"id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07077"],"award-info":[{"award-number":["23K07077"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12194-026-01056-8","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:15:20Z","timestamp":1777277720000},"page":"792-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal timing of the cumulative dose and factors related to acute urinary toxicity in prostate cancer treated using magnetic resonance linear accelerator"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4257-5342","authenticated-orcid":false,"given":"Shohei","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kadoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wingyi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisamichi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Jingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"5","key":"1056_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ijrobp.2020.12.015","volume":"109","author":"BA McDonald","year":"2021","unstructured":"McDonald BA, Vedam S, Yang J, et al. Initial feasibility and clinical implementation of daily MR-guided adaptive head and neck cancer radiation therapy on a 1.5 T MR-Linac system: prospective R-IDEAL 2a\/2b systematic clinical evaluation of technical innovation. Int J Radiation Oncology* Biology* Phys. 2021;109(5):1606\u201318.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"1056_CR2","doi-asserted-by":"publisher","first-page":"1172135","DOI":"10.3389\/fonc.2023.1172135","volume":"13","author":"H Wang","year":"2023","unstructured":"Wang H, Liu X, Song Y, et al. Feasibility study of adaptive radiotherapy for esophageal cancer using artificial intelligence autosegmentation based on MR-Linac. Front Oncol. 2023;13:1172135.","journal-title":"Front Oncol"},{"key":"1056_CR3","doi-asserted-by":"publisher","first-page":"100744","DOI":"10.1016\/j.ctro.2024.100744","volume":"45","author":"L Merckel","year":"2024","unstructured":"Merckel L, Pomp J, Hackett S, et al. Stereotactic body radiotherapy of central lung tumours using a 1.5 T MR-linac: First clinical experiences. Clin translational radiation Oncol. 2024;45:100744.","journal-title":"Clin translational radiation Oncol"},{"issue":"3","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/cancers14030716","volume":"14","author":"T Stanescu","year":"2022","unstructured":"Stanescu T, Shessel A, Carpino-Rocca C, et al. MRI-guided online adaptive stereotactic body radiation therapy of liver and pancreas tumors on an MR-linac system. Cancers. 2022;14(3):716.","journal-title":"Cancers"},{"key":"1056_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejmp.2020.09.026","volume":"80","author":"R Ruggieri","year":"2020","unstructured":"Ruggieri R, Rigo M, Naccarato S, et al. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time. Physica Med. 2020;80:34\u201341.","journal-title":"Physica Med"},{"issue":"12","key":"1056_CR6","doi-asserted-by":"publisher","first-page":"e14122","DOI":"10.1002\/acm2.14122","volume":"24","author":"S Tanaka","year":"2023","unstructured":"Tanaka S, Kadoya N, Ishizawa M, et al. Evaluation of Unity 1.5 T MR-linac plan quality in patients with prostate cancer. J Appl Clin Med Phys. 2023;24(12):e14122.","journal-title":"J Appl Clin Med Phys"},{"key":"1056_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctro.2020.10.005","volume":"26","author":"J Mohajer","year":"2021","unstructured":"Mohajer J, Dunlop A, Mitchell A, et al. Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer. Clin Translational Radiation Oncol. 2021;26:1\u20137.","journal-title":"Clin Translational Radiation Oncol"},{"key":"1056_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2022.09.004","volume":"176","author":"T Willigenburg","year":"2022","unstructured":"Willigenburg T, Zachiu C, Bol GH, et al. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion. Radiother Oncol. 2022;176:25\u201330.","journal-title":"Radiother Oncol"},{"key":"1056_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.phro.2020.12.001","volume":"17","author":"J Yang","year":"2021","unstructured":"Yang J, Vedam S, Lee B, et al. Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator. Phys Imaging Radiation Oncol. 2021;17:20\u20134.","journal-title":"Phys Imaging Radiation Oncol"},{"issue":"2","key":"1056_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12194-024-00800-2","volume":"17","author":"R Tozuka","year":"2024","unstructured":"Tozuka R, Kadoya N, Arai K, et al. Assessment of the deep learning-based gamma passing rate prediction system for 1.5 T magnetic resonance-guided linear accelerator. Radiol Phys Technol. 2024;17(2):451\u20137.","journal-title":"Radiol Phys Technol"},{"key":"1056_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ctro.2019.04.001","volume":"18","author":"D Winkel","year":"2019","unstructured":"Winkel D, Bol GH, Kroon PS, et al. Adaptive radiotherapy: the Elekta Unity MR-linac concept. Clin translational radiation Oncol. 2019;18:54\u20139.","journal-title":"Clin translational radiation Oncol"},{"issue":"2","key":"1056_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.21037\/tcr-23-1649","volume":"13","author":"N Takahashi","year":"2024","unstructured":"Takahashi N, Tanaka S, Umezawa R, et al. Beginning of clinical treatment using the 1.5 Tesla MR-Linac system in Japan: a narrative review. Translational Cancer Res. 2024;13(2):1131.","journal-title":"Translational Cancer Res"},{"key":"1056_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.radonc.2021.01.022","volume":"157","author":"O Bohoudi","year":"2021","unstructured":"Bohoudi O, Bruynzeel AM, Tetar S, et al. Dose accumulation for personalized stereotactic MR-guided adaptive radiation therapy in prostate cancer. Radiother Oncol. 2021;157:197\u2013202.","journal-title":"Radiother Oncol"},{"key":"1056_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.radonc.2022.04.022","volume":"171","author":"T Willigenburg","year":"2022","unstructured":"Willigenburg T, van der Velden JM, Zachiu C, et al. Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy. Radiother Oncol. 2022;171:182\u20138.","journal-title":"Radiother Oncol"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.radonc.2019.08.027","volume":"141","author":"P Ghadjar","year":"2019","unstructured":"Ghadjar P, Fiorino C, af Rosensch\u00f6ld PM, et al. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiother Oncol. 2019;141:5\u201313.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1056_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1118\/1.4894702","volume":"42","author":"O Weistrand","year":"2015","unstructured":"Weistrand O, Svensson S. The ANACONDA algorithm for deformable image registration in radiotherapy. Med Phys. 2015;42(1):40\u201353.","journal-title":"Med Phys"},{"issue":"12","key":"1056_CR17","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1016\/S1470-2045(22)00544-7","volume":"23","author":"JM Martin","year":"2022","unstructured":"Martin JM, Richardson M, Siva S, et al. Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy. Lancet Oncol. 2022;23(12):e534\u201343.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1056_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ijrobp.2010.03.040","volume":"80","author":"R Malik","year":"2011","unstructured":"Malik R, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS). Int J Radiation Oncology* Biology* Phys. 2011;80(4):1080\u20136.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"1","key":"1056_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.radonc.2014.02.006","volume":"111","author":"V Carillo","year":"2014","unstructured":"Carillo V, Cozzarini C, Rancati T, et al. Relationships between bladder dose\u2013volume\/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer. Radiother Oncol. 2014;111(1):100\u20135.","journal-title":"Radiother Oncol"},{"issue":"2","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.radonc.2013.07.019","volume":"109","author":"MJ Steggerda","year":"2013","unstructured":"Steggerda MJ, Witteveen T, van den Boom F, et al. Is there a relation between the radiation dose to the different sub-segments of the lower urinary tract and urinary morbidity after brachytherapy of the prostate with I-125 seeds? Radiother Oncol. 2013;109(2):251\u20135.","journal-title":"Radiother Oncol"},{"issue":"7","key":"1056_CR21","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/mp.12256","volume":"44","author":"KK Brock","year":"2017","unstructured":"Brock KK, Mutic S, McNutt TR, et al. Use of image registration and fusion algorithms and techniques in radiotherapy: Report of the AAPM Radiation Therapy Committee Task Group 132. Med Phys. 2017;44(7):e43\u201376.","journal-title":"Med Phys"},{"issue":"2","key":"1056_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","volume":"88","author":"P Ghadjar","year":"2014","unstructured":"Ghadjar P, Zelefsky MJ, Spratt DE, et al. Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiation Oncology* Biology* Phys. 2014;88(2):339\u201344.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"12","key":"1056_CR23","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.ejmp.2016.08.013","volume":"32","author":"I Improta","year":"2016","unstructured":"Improta I, Palorini F, Cozzarini C, et al. Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer. Physica Med. 2016;32(12):1681\u20139.","journal-title":"Physica Med"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.radonc.2020.09.021","volume":"154","author":"AM Werensteijn-Honingh","year":"2021","unstructured":"Werensteijn-Honingh AM, J\u00fcrgenliemk-Schulz IM, Gadellaa-Van Hooijdonk CG, et al. Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases. Radiother Oncol. 2021;154:110\u20137.","journal-title":"Radiother Oncol"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctro.2021.11.001","volume":"32","author":"A Gupta","year":"2022","unstructured":"Gupta A, Dunlop A, Mitchell A, et al. Online adaptive radiotherapy for head and neck cancers on the MR linear accelerator: introducing a novel modified adapt-to-shape approach. Clin translational radiation Oncol. 2022;32:48\u201351.","journal-title":"Clin translational radiation Oncol"},{"issue":"6","key":"1056_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/jrr\/rrae088","volume":"65","author":"M Saito","year":"2024","unstructured":"Saito M, Abe K, Tsuneda M, et al. Feasibility of creating a daily adaptive plan using automatic DIR-created target and OARs contours in patients with prostate cancer magnetic-resonance-guided adaptive radiotherapy. J Radiat Res. 2024;65(6):845\u201350.","journal-title":"J Radiat Res"},{"key":"1056_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ctro.2021.01.002","volume":"27","author":"T Willigenburg","year":"2021","unstructured":"Willigenburg T, de Keizer M, Peters DM. Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator. Clin translational radiation Oncol. 2021;27:50\u20136.","journal-title":"Clin translational radiation Oncol"},{"key":"1056_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.phro.2021.07.010","volume":"19","author":"M de Keizer","year":"2021","unstructured":"de Keizer M, de Groot-van Breugel DM, Raaymakers EN. On-line daily plan optimization combined with a virtual couch shift procedure to address intrafraction motion in prostate magnetic resonance guided radiotherapy. Phys Imaging Radiation Oncol. 2021;19:90\u20135.","journal-title":"Phys Imaging Radiation Oncol"},{"key":"1056_CR29","doi-asserted-by":"crossref","unstructured":"Dassen MG, Neijndorff B, Betgen A et al. Simulation of focal boosting in online adaptive MRI-guided SBRT for patients with locally advanced prostate cancer with seminal vesicle involvement. Practical Radiat Oncol. 2025;15(2):196\u2013204.","DOI":"10.1016\/j.prro.2024.10.009"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.ctro.2024.100742","volume":"46","author":"K Sritharan","year":"2024","unstructured":"Sritharan K, Daamen L, Pathmanathan A, et al. MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study. Clin translational radiation Oncol. 2024;46:100742.","journal-title":"Clin translational radiation Oncol"},{"key":"1056_CR31","doi-asserted-by":"crossref","unstructured":"Rusu SD, Smith BR, St-Aubin JJ et al. Surrogate gating strategies for the Elekta Unity MR\u2010Linac gating system. J Appl Clin Med Phys. 2025;26(2):e14566.","DOI":"10.1002\/acm2.14566"},{"issue":"4","key":"1056_CR32","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/mp.16870","volume":"51","author":"P Uijtewaal","year":"2024","unstructured":"Uijtewaal P, Borman P, Cote B, et al. Performance characterization of a novel hybrid dosimetry insert for simultaneous spatial, temporal, and motion-included dosimetry for MR\u2010linac. Med Phys. 2024;51(4):2983\u201397.","journal-title":"Med Phys"},{"issue":"5","key":"1056_CR33","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/mp.14104","volume":"47","author":"N Kadoya","year":"2020","unstructured":"Kadoya N, Tanaka S, Kajikawa T, et al. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT\u2010based radiomics. Med Phys. 2020;47(5):2197\u2013205.","journal-title":"Med Phys"},{"issue":"1","key":"1056_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13014-021-01810-9","volume":"16","author":"Y Sugai","year":"2021","unstructured":"Sugai Y, Kadoya N, Tanaka S, et al. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients. Radiat Oncol. 2021;16(1):80.","journal-title":"Radiat Oncol"},{"issue":"1","key":"1056_CR35","doi-asserted-by":"publisher","first-page":"8899","DOI":"10.1038\/s41598-022-12170-z","volume":"12","author":"S Tanaka","year":"2022","unstructured":"Tanaka S, Kadoya N, Sugai Y, et al. A deep learning-based radiomics approach to predict head and neck tumor regression for adaptive radiotherapy. Sci Rep. 2022;12(1):8899.","journal-title":"Sci Rep"},{"issue":"1","key":"1056_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijrobp.2010.09.027","volume":"82","author":"C Cozzarini","year":"2012","unstructured":"Cozzarini C, Fiorino C, Da Pozzo LF, et al. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. Int J Radiation Oncology* Biology* Phys. 2012;82(1):191\u20139.","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"4","key":"1056_CR37","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(15)00567-7","volume":"17","author":"S Aluwini","year":"2016","unstructured":"Aluwini S, Pos F, Schimmel E, et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial. Lancet Oncol. 2016;17(4):464\u201374.","journal-title":"Lancet Oncol"},{"issue":"9","key":"1056_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.clon.2016.04.041","volume":"28","author":"V Stankovic","year":"2016","unstructured":"Stankovic V, D\u017eamic Z, Pekmezovic T, et al. Acute and late genitourinary toxicity after 72 Gy of conventionally fractionated conformal radiotherapy for localised prostate cancer: impact of individual and clinical parameters. Clin Oncol. 2016;28(9):577\u201386.","journal-title":"Clin Oncol"}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-026-01056-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-026-01056-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-026-01056-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:47:15Z","timestamp":1781650035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-026-01056-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s12194-026-01056-8","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"value":"1865-0333","type":"print"},{"value":"1865-0341","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Keiichi Jingu has rewarded a research grant from Elekta.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional ethics committee. All procedures were conducted in accordance with institutional and national ethical standards and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given its retrospective design, the requirement for informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}